Concepedia

Aleksi Tornio

AT

43

Publications

2K

Citations

27

H-Index

2005

Active since

Affiliations

University of Helsinki(Current)

Helsinki University Hospital

University of Turku

Turku University Hospital

Aleksi Tornio is an author at University of Helsinki specializing in pharmacology, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2005–2024

43

Publications

43

SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid

Aleksi Tornio, Juha Vakkilainen, Mikko Neuvonen et al. · Pharmacogenetics and Genomics · 2015 · 406 citations

Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions

Aleksi Tornio, Anne M. Filppula, O Kailari et al. · Clinical Pharmacology & Therapeutics · 2014 · 139 citations

, , +20

Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone

Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen et al. · Drug Metabolism and Disposition · 2007 · 112 citations

The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo

Aleksi Tornio, Mikko Niemi, Mikko Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2008 · 89 citations

Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide

Mikko Niemi, Aleksi Tornio, Marja K. Pasanen et al. · European Journal of Clinical Pharmacology · 2006 · 85 citations

,

Rows per page

1–5 of 43